Håkansson, Claes
Torisson, Gustav
Londos, Elisabet
Hansson, Oskar
van Westen, Danielle
Funding for this research was provided by:
Lund University
Article History
Received: 27 September 2018
Accepted: 3 January 2019
First Online: 17 January 2019
Compliance with ethical standards
:
: This study was funded by the European Research Council, the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Marianne and Marcus Wallenberg Foundation, the Strategic Research Area MultiPark (Multidisciplinary Research in Parkinson’s Disease) at Lund University, the Swedish Alzheimer Foundation, the Swedish Brain Foundation, The Parkinson Foundation of Sweden, The Parkinson Research Foundation, the Skåne University Hospital Foundation and the Swedish government under the ALF agreement.
: OH has received institutional research support from Roche, GE Healthcare, Biogen, AVID Radiopharmaceuticals, Fujirebio and Euroimmun. OH has received consultancy/speaker fees (paid to the institution) from Lilly, Roche and Fujirebio.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.
: Informed consent was obtained from all individual participants included in the BioFINDER study.